PNB Housing Finance
BSE SENSEX
33,043
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Avg Val, INRm
Free float (%)
S&P CNX
10,295
PNBHF IN
166
231 / 3.6
1715/789
-14/-7/-
690
61.1
25 Oct 2017
2QFY18 Results Update | Sector: Financials
CMP: INR1394
TP: INR1750 (+25%)
Buy
Growth story continues
PNB Housing Finance’s (PNBHF) 2QFY18 PAT grew robustly by 51% YoY to
INR2.08b, led by its strong AUM growth, YoY improvement in margins and
lower C/I ratio (albeit off a high base).
Disbursements grew 45% YoY to INR74b. While this is certainly a very strong
performance, it was a tad lower than disbursements in 1QFY18, suggesting
some impact of RERA, and possibly GST.
Generally, the second quarter is
seasonally strong in terms of disbursements for an HFC.
AUM growth of 47% YoY was in line with estimates. The mix has remained
largely stable on both QoQ and YoY basis.
C/I ratio (calculated) declined over 1,200bp YoY and 160bp QoQ to 23%. The
sequential improvement is commendable, in our view.
One of the key factors
driving this is improving employee productivity.
As per company disclosures,
both disbursements/employee and loans outstanding/employee have
increased at ~20% CAGR over the past two years (note that this number does
not account for off-roll sales staff). We believe continued operating leverage is
key to RoA/RoE improvement, and thus, for valuations to sustain.
Valuation view:
PNBHF continues to deliver strong growth in its loan book.
Increasing geographical spread and new branch openings (110 branches in
FY20E v/s 66 in FY17) are expected to result in the loan book growing to ~INR1t
by FY20 (37% CAGR). With the pace of investments slowing down, coupled with
operating leverage benefits kicking in, the expense ratio is set to decline
meaningfully. Credit costs, however, are expected to inch up marginally on
account of portfolio seasoning. All these factors put together are expected to
drive 41% PAT CAGR over FY17-20E, with RoE inching toward high-teens over
the medium term. We upgrade our FY18-20 EPS estimates by 2-9%.
Buy
with a
target price of INR1,750 (3.8x Sep 2019E BVPS, 22x Sep 2019E EPS).
Financials & Valuations (INR b)
Y/E March
2018E 2019E 2020E
NII
15.7
21.0
27.9
PPP
PAT
EPS (INR)
BV/Sh. (INR)
RoAA (%)
RoE (%)
Payout (%)
P/E (x)
P/BV (x)
Div. Yield (%)
15.8
8.7
52.5
371.1
1.7
15.0
20.9
26.5
3.8
0.7
21.0
11.0
66.5
423.7
1.5
16.7
20.9
21.0
3.3
0.9
28.1
14.7
88.8
494.0
1.5
19.4
20.9
15.7
2.8
1.1
Estimate change
TP change
Rating change
Research Analyst: Piran Engineer
(Piran.Engineer@MotilalOswal.com); +91 22 3980 4393 |
Alpesh Mehta
(Alpesh.Mehta@MotilalOswal.com); +91 22 3982 5415
Nitin Aggarwal
(Nitin.Aggarwal@MotilalOswal.com); +91 22 3982 5540
| Anirvan Sarkar
(Anirvan.Sarkar@MotilalOswal.com); +91 22 3982 5505
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.